RHEUMATOLOGY

Scope & Guideline

Exploring New Horizons in Rheumatic Disease Management

Introduction

Welcome to the RHEUMATOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of RHEUMATOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1462-0324
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1952 to 1995, from 1998 to 2024
AbbreviationRHEUMATOLOGY / RHEUMATOLOGY
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'RHEUMATOLOGY' is dedicated to advancing the understanding, diagnosis, and treatment of rheumatic diseases. It focuses on a wide array of topics that encompass clinical, translational, and basic research, highlighting the multidisciplinary nature of rheumatology.
  1. Clinical Research in Rheumatology:
    The journal publishes studies examining clinical outcomes, treatment efficacy, and patient-reported outcomes in various rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, and spondyloarthritis.
  2. Translational Research:
    Research that bridges the gap between laboratory findings and clinical applications is emphasized, including studies on biomarkers, genetic predispositions, and the mechanisms of disease.
  3. Innovative Diagnostic Techniques:
    The use of advanced imaging techniques, such as ultrasound and MRI, and novel diagnostic criteria for conditions like giant cell arteritis and ankylosing spondylitis are frequently reported.
  4. Management Guidelines and Quality of Care:
    The journal provides insights into the development and implementation of clinical guidelines for the management of rheumatic diseases, ensuring high standards of patient care.
  5. Autoimmunity and Inflammation:
    The exploration of autoimmune mechanisms and inflammatory pathways in rheumatic diseases is a significant focus, including studies on cytokine profiles and immune responses.
  6. Patient-Centered Research:
    The journal values patient perspectives and experiences, integrating qualitative research to inform treatment approaches and healthcare delivery.
The journal has shown a dynamic adaptation to emerging trends and themes in rheumatology, reflecting the evolving landscape of patient care, research, and technology. The following areas have gained significant traction in recent publications.
  1. Biologics and Targeted Therapies:
    Research on the efficacy and safety of newer biologic treatments, particularly Janus kinase inhibitors and IL-17 inhibitors, has surged, highlighting their role in managing difficult-to-treat rheumatic diseases.
  2. Digital Health and Telemedicine:
    The integration of digital tools for monitoring and managing rheumatic diseases has become prominent, especially in response to the COVID-19 pandemic, leading to studies evaluating their effectiveness and patient acceptability.
  3. Microbiome Research:
    There is a growing interest in the role of the microbiome in rheumatic diseases, with studies investigating how gut and oral microbiota influence disease activity and treatment response.
  4. Personalized Medicine Approaches:
    The journal is increasingly focused on research that aims to tailor treatments based on genetic, biochemical, and phenotypic characteristics of patients, moving away from one-size-fits-all strategies.
  5. Longitudinal and Real-World Data Studies:
    Emerging trends include the use of real-world data to assess treatment effectiveness and patient outcomes, emphasizing the importance of observational studies in understanding the complexities of rheumatic diseases.

Declining or Waning

While the journal maintains a robust focus on various aspects of rheumatology, certain themes have seen a decline in prominence in recent years. This may reflect shifts in research priorities or advancements in understanding specific diseases.
  1. Traditional Pharmacological Treatments:
    There has been a noticeable decrease in studies focused solely on traditional disease-modifying anti-rheumatic drugs (DMARDs) without the integration of newer biologic or targeted therapies, as the field moves towards personalized medicine.
  2. Epidemiological Studies:
    Although still relevant, the frequency of large-scale epidemiological studies assessing disease prevalence and incidence has diminished as the focus shifts to more targeted, mechanistic research.
  3. Longitudinal Studies of Established Conditions:
    Research focusing on the long-term outcomes of well-established rheumatic diseases, particularly those with less immediate clinical impact, has waned in favor of studies on emerging conditions and novel therapies.
  4. Basic Science without Clinical Relevance:
    There is less emphasis on basic science research that does not have clear clinical implications or pathways to application in patient care, as the journal prioritizes translational and applied research.

Similar Journals

Open Access Rheumatology-Research and Reviews

Connecting Minds, Sharing Discoveries in Rheumatology.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Acta Reumatologica Portuguesa

Transforming clinical practices with cutting-edge findings.
Publisher: PUBLISAUDE-EDICOES MEDICAS LDAISSN: 0303-464XFrequency: 4 issues/year

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

Modern Rheumatology

Transforming Research into Clinical Excellence
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Pioneering insights in the field of rheumatology.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.

Current Treatment Options in Rheumatology

Advancing rheumatology through innovative treatment insights.
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Treatment Options in Rheumatology, published by SPRINGERNATURE, is a pivotal journal focused on advancing the field of rheumatology through the dissemination of cutting-edge research and comprehensive reviews. With an emphasis on current therapeutic strategies, this journal aims to provide healthcare professionals, researchers, and students with up-to-date information on the latest treatment modalities for rheumatic diseases. Although it operates under a subscription model, it offers a platform for sharing significant findings that can influence clinical practice and policy within the field of rheumatology. By promoting insightful discussions and collaborations, Current Treatment Options in Rheumatology plays a crucial role in shaping the future of rheumatic disease management and improving patient outcomes.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Navigating the complexities of rheumatology for better outcomes.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

Rheumatology Advances in Practice

Transforming insights into practice for rheumatology professionals.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Nature Reviews Rheumatology

Connecting global expertise in rheumatology.
Publisher: NATURE PORTFOLIOISSN: 1759-4790Frequency: 12 issues/year

Nature Reviews Rheumatology is a premier academic journal published by NATURE PORTFOLIO, dedicated to the field of rheumatology. With an impressive impact factor reflecting its high citation rate and relevance within the scientific community, it ranks in the Q1 category for rheumatology, showcasing its essential role in disseminating cutting-edge research and reviews. The journal serves as a vital resource for researchers, clinicians, and students alike, presenting comprehensive articles that cover the latest developments, therapeutic advancements, and emerging trends in rheumatic diseases. With access options, including open access, it ensures that valuable insights are within reach for all stakeholders in the field. Situated in the United Kingdom and intersecting with a global audience, Nature Reviews Rheumatology stands as an authoritative voice, fostering education and innovation to improve patient outcomes and enhance the understanding of rheumatological conditions.

Current Rheumatology Reviews

Shaping the future of rheumatology through rigorous reviews.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Reumatologia

Enhancing visibility of crucial research in Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.